Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GuideAI HealthNEOE:GDAI 11 Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus rates NEOE:GDAI with a GF Score™ of 11/100. Among 576 Healthcare Providers & Services companies, GuideAI Health ranks worse than 173610.94% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. GuideAI Health's annualized net income for the quarter that ended in Mar. 2026 was C$-2.89 Mil. GuideAI Health's average shareholder tangible equity for the quarter that ended in Mar. 2026 was C$-2.42 Mil. Therefore, GuideAI Health's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.
The historical rank and industry rank for GuideAI Health's Return-on-Tangible-Equity or its related term are showing as below:
NEOE:GDAI's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.17 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
GuideAI Health (NEOE:GDAI) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
GuideAI Health Return-on-Tangible-Equity Related Terms
GuideAI Health Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for GuideAI Health's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GuideAI Health Return-on-Tangible-Equity Chart
GuideAI Health Annual Data
Trend
Jun23
Jun24
Jun25
Return-on-Tangible-Equity
0.00
0.00
0.00
GuideAI Health Quarterly Data
Jun23
Jun24
Mar25
Jun25
Mar26
Return-on-Tangible-Equity
0.00
0.00
0.00
0.00
0.00
NEOE:GDAI vs VEEV, BTSG, HQY: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, GuideAI Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GuideAI Health Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GuideAI Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where GuideAI Health's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
GuideAI Health (NEOE:GDAI) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on GuideAI Health and its competitors. According to the industry distribution chart, GuideAI Health ranks #999999 out of 576 companies in the Healthcare Providers & Services industry.
Is GuideAI Health's Return-on-Tangible-Equity too high?
GuideAI Health's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, GuideAI Health ranks #999999 out of 576 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, GuideAI Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does GuideAI Health's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, GuideAI Health ranks #999999 out of 576 companies for Return-on-Tangible-Equity. This places GuideAI Health in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on GuideAI Health and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GuideAI Health's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GuideAI Health stock overvalued right now?
GuideAI Health (NEOE:GDAI) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. GuideAI Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For GuideAI Health (NEOE:GDAI), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
11GF Score
Get the complete analysis for NEOE:GDAI
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEOE:GDAI has been successfully added to your 
